EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2


Van Laere K., Varrone A., Booij J., Borght T. V., Nobili F., Kapucu O. L., ...More

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.37, no.2, pp.434-442, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 37 Issue: 2
  • Publication Date: 2010
  • Doi Number: 10.1007/s00259-009-1265-z
  • Journal Name: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.434-442
  • Keywords: Brain, Dopamine, D2 receptor, SPECT, PET, Parkinsonism, MULTIPLE SYSTEM ATROPHY, POSITRON-EMISSION-TOMOGRAPHY, PARKINSONS-DISEASE, DIFFERENTIAL-DIAGNOSIS, HUNTINGTONS-DISEASE, AUTOMATED QUANTIFICATION, COMPUTED-TOMOGRAPHY, I-123 IODOBENZAMIDE, PET, NEUROLEPTICS
  • Gazi University Affiliated: Yes

Abstract

The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice.